Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Aging Clinical and Experimental Research|March 8, 2017
Weight change and risk of hyperglycaemia in elderly womenKatrine Dragsbæk, Jesper S Neergaard, Claus Christiansen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 14, 2007
Evaluation of cartilage damage by measuring collagen degradation products in joint extracts in a traumatic model of osteoarthritisRasmus H Nielsen, Reinout Stoop, Diana J Leeming, et al.
Circulation|September 29, 2004
Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesisLászló B Tankó, Jens M Bruun, Peter Alexandersen, et al.
Menopause (New York, N.Y.)|June 25, 2013
Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in ratsMichael Feigh, Kim V Andreassen, Sara T Hjuler, et al.
Bone|November 8, 2005
Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bonePatrick Garnero, Olivier Borel, Evelyne Gineyts, et al.
Menopause (New York, N.Y.)|September 10, 2004
Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM)Stephan Christgau, László B Tankó, Paul A C Cloos, et al.
Arthritis and Rheumatism|May 1, 2007
Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradationMorten Asser Karsdal, Eren Ufuk Sumer, Helle Wulf, et al.
Psychiatric Genetics|March 16, 2006
Estrogen receptor alpha and risk for cognitive impairment in postmenopausal womenLine Olsen, Henrik B Rasmussen, Thomas Hansen, et al.
Bone|July 12, 2005
Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritisYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Bone|July 28, 2009
Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMDDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
Pageof 20